Neurotrack is transforming the diagnosis of Alzheimer’s disease. Through a safe and non-invasive test, its technology can predict the risk of developing mild cognitive impairment and Alzheimer’s disease years before symptoms occur.

Type
Private
HQ
Redwood City, US
Founded
2012
Size (employees)
25 (est)+5%
Neurotrack was founded in 2012 and is headquartered in Redwood City, US
Report incorrect company information

Key People/Management at Neurotrack

Elli Kaplan

Elli Kaplan

Co-Founder and CEO
Caitlyn Krebs

Caitlyn Krebs

Chief Operating Officer

Neurotrack Office Locations

Neurotrack has offices in Richmond and Redwood City
Redwood City, US (HQ)
399 Bradford St
Richmond, US (HQ)
4200 Grove Ave
Show all (2)
Report incorrect company information

Neurotrack Financials and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$26.1 m

Latest funding size

$13.70 m

Time since last funding

2 months ago

Investors

Neurotrack's latest funding round in March 2018 was reported to be $13.7 m. In total, Neurotrack has raised $26.1 m
Show all financial metrics
Report incorrect company information

Neurotrack News and Updates

Neurotrack wins medical innovation challenge with Alzheimer's tech

Company uses eye-tracking technology to predict and help prevent the development of the disease.
Report incorrect company information